PLAT and Rare hereditary thrombophilia: In another study, elevated plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) (Zuo et al., 2021) were noted indicating derangements in the fibrinolytic pathways and reflective of the hemostatic system's reaction to a COVID-19-induced thrombophilia.